StreetInsider.com News Articles

Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Thu, 11 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, is pleased to announce it will be presenting at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17^th, 2026.

At Planet MicroCap, Dr. Jeffrey Sherman will provide an update on Telescope's business including its DirectInject-LC™ reaction sampling products, a newly announced technology development collaboration with AGI SDA to develop next-generation automated chemistry reactors (see news release dated March 16, 2026), and the Company's growing roster of

Telescope Innovations to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Thu, 11 Jun 2026 08:00:00 -0400

Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award

Fri, 05 Jun 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") congratulates its Founder and Chief Technology Officer, Professor Jason Hein, on receiving the 2026 SCI Canada LeSueur Memorial Award from the Society of Chemical Industry ("SCI").

Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg

Administered by the Society of Chemical Industry, a professional body founded in London in

Telescope Innovations Founder and CTO, Professor Jason Hein, Receives 2026 SCI Canada LeSueur Memorial Award

Fri, 05 Jun 2026 08:00:00 -0400

Figure 1. The 2026 LeSeueur Memorial Award Presented to Professor Jason Hein

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8923/300261_328197891408ab84_001full.jpg

Administered by the Society of Chemical Industry, a professional body founded in London in

Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company

Mon, 01 Jun 2026 08:00:00 -0400

Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a leading developer of intelligent automation and advanced chemical manufacturing technologies, today announced that is has signed an agreement with a major global pharmaceutical company to deliver a Self-Driving Lab (SDL) platform at the company's European operations. The deployment, Telescope's third SDL placement in its 2026 fiscal year, is expected to be installed within the coming months.

A MILESTONE BUILDING ON TWO PRIOR SUCCESSES

The agreement

Telescope Innovations Secures Third Self-Driving Lab Deployment with Major Global Pharmaceutical Company

Mon, 01 Jun 2026 08:00:00 -0400

Continued adoption by world-leading pharmaceutical partners underscores growing industry demand for autonomous lab technology

A MILESTONE BUILDING ON TWO PRIOR SUCCESSES

The agreement

Telescope Innovations Shares Spring 2026 Conference and Events Lineup

Mon, 11 May 2026 08:00:00 -0400

The Company is actively engaging with pharmaceutical, academic, and investor audiences to strengthen existing and novel partnerships

Vancouver, British Columbia--(Newsfile Corp. - May 11, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lectures on our advanced automation technology for chemical R&D: Self-Driving Labs, and DirectInject-LC™.

Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to report on outreach, marketing, and educational activities, both past and planned for spring 2026. Our participation includes presentations, exhibitions and keynote lectures on our advanced automation technology for chemical R&D: Self-Driving Labs, and DirectInject-LC™.

Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations. Year-to-date gross revenues increased

Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026

Mon, 13 Apr 2026 18:00:00 -0400

Revenues are consistent with budget expectations and ahead of Q2 2025 comparative revenues

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations. Year-to-date gross revenues increased

Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation

Mon, 23 Mar 2026 08:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 23, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries. The Company is pleased to announce that Dr. Joel M. Hawkins has expanded his consulting role with Telescope. Dr. Hawkins is an industry-wide authority in automating complex chemistry workflows and enabling the high-value kinetic and mechanistic datasets needed for chemical process development. His expertise will now support Telescope's expanding work in automated chemistry sampling technologies and autonomous, Self-Driving Laboratories.

Dr. Hawkins has been

Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation

Mon, 23 Mar 2026 08:00:00 -0400

Dr. Hawkins has been

Telescope Innovations and AGI SDA Launch Technology Development Collaboration

Mon, 16 Mar 2026 08:00:00 -0400

The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs

Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company") is a developer of enabling technologies and services for the global pharmaceutical and high value chemical industries, with established leadership in sampling systems for monitoring chemical and biological processes. The Company is pleased to announce that it has signed a Development and Collaboration Agreement (the "Agreement") with AGI Group's Synthesis, Digitization, and Automation program ("AGI SDA"). AGI SDA is an innovator in automated laboratory and

Telescope Innovations and AGI SDA Launch Technology Development Collaboration

Mon, 16 Mar 2026 08:00:00 -0400

The chemistry technology companies aim to develop a next-generation chemical reactor for automated labs

Telescope Strengthens Investor Communications Strategy

Thu, 12 Mar 2026 08:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries,has rescoped its previously announced digital marketing agreement dated September 19, 2025, with Gold Standard Media, LLC ("GSM") and its affiliates. In connection with the reduction in scope GSM has refunded the Company $300,000 in previously paid fees so that Telescope is able to use an additional marketing vehicle to support its Investor Marketing activities.

The Company further announces that it has engaged Curzio Research Holdings,

Telescope Strengthens Investor Communications Strategy

Thu, 12 Mar 2026 08:30:00 -0400

The Company further announces that it has engaged Curzio Research Holdings,

VIDEO - BTV Visits Atlas Salt, Graphene Manufacturing, Telescope Innovations, Nevada Organic Phosphate, Maple Gold, Intrepid Metals and Nine Mile Metals

Wed, 04 Mar 2026 06:00:00 -0400

Watch on BNN Bloomberg national
Wednesday, March 4 at 7:30 PM EST & Saturday, March 7 at 8 PM EST